Portfolio Management Strategies in Biopharma

This white paper explores innovative portfolio management strategies for biopharmaceutical companies, emphasizing the importance of aligning R&D with commercial success. It discusses the challenges faced by the industry, including the pitfalls of pursuing 'me too' drugs and the need for robust evidence to support therapeutic innovations. The paper is part of Trinity's Industry Impact Series, aimed at revolutionizing drug development and commercialization in the evolving biopharma landscape.